| Ureter Neoplasm studied in …STUDIED_INderived71 of 71show fewer |
|---|
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Muscle Invasive Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244384Phase 3 · active not recruiting Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00902590active not recruiting A Genotype-Phenotype Urothelial Cancer Registry · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05614739Phase 1 · recruiting FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3 · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237780Phase 2 · active not recruiting Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05756569Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942331Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Ureter Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03291028active not recruiting Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04953104Phase 2 · active not recruiting ARID1A and/or KDM6A Mutation and CXCL13 Expression · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03288545Phase 1/Phase 2 · terminated A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637594Phase 3 · active not recruiting Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848519Phase 2 · active not recruiting Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06349668Phase 3 · recruiting Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Benign Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07125547Phase 2 · recruiting Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer · condition mapped PROBABILISTIC · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122172Phase 2 · terminated Afatinib in Advanced Refractory Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567409Phase 2 · completed Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598761recruiting Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC · condition mapped PROBABILISTIC · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06652022NA · recruiting Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03219333Phase 2 · completed A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513952Phase 2 · completed Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06469229not yet recruiting Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326871Phase 1/Phase 2 · completed A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427993unknown Urine DNA Methylation Detection for Hematuria Evaluation · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03590054Phase 1 · completed Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02607709NA · suspended Lymphadenectomy in Urothelial Carcinoma · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02643043NA · completed UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04398368Phase 2 · terminated Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05739812NA · unknown The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397394Phase 2 · terminated Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625556recruiting Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02612194Phase 2 · terminated LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03520231Phase 2 · completed Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043662unknown UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02430779NA · completed Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749892Phase 2 · completed Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01993979Phase 3 · unknown A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01846520NA · completed Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935347Phase 2 · withdrawn Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178241Phase 2 · completed Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197414recruiting Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02665039Phase 2 · completed A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01282463Phase 2 · completed Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02300610Phase 1 · completed Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01191892Phase 2 · completed Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01844947Phase 1 · completed Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02438865Phase 2 · completed Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy. · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03013920completed CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03296306Phase 3 · unknown Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193788Phase 3 · unknown Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01328574Phase 2 · completed TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01182168Phase 1 · completed Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01639521Phase 2 · withdrawn Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072150Phase 2 · completed Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009867Phase 2 · completed Arsenic Trioxide in Treating Patients With Urothelial Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01426126Phase 2 · completed Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00661609Phase 2 · completed A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer · condition mapped CURATED_BROADER · 71 trials mapped (27 active) | — | — | Malignant Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101608Phase 2 · completed Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium · condition mapped ONTOLOGY_EXACT · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994188NA · unknown A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077688Phase 2 · completed TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium · condition mapped ALIAS · 71 trials mapped (27 active) | — | — | Ureter Neoplasm | 1 | Observed | clinicaltrials | graph → |